TSCAN THERAPEUTICS, INC. (TCRX) Operating cash flow 2020–2025
TSCAN THERAPEUTICS, INC. (TCRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$135.3MFY2025 · since FY2020: -$3.0M → -$135.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$135.3M | -22.1% |
| FY2024 | -$110.8M | -80.6% |
| FY2023 | -$61.4M | +7.7% |
| FY2022 | -$66.5M | -36.6% |
| FY2021 | -$48.7M | -1510.2% |
| FY2020 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice